The Shokeen Lab at WashU School of Medicine, a multidisciplinary lab focused on developing novel contrast agents for non-invasive imaging of multiple myeloma, a plasma cell cancer in the bone marrow, with the goal of monitoring disease progression and therapeutic response, currently has an opening for 1-2 undergraduate students for the upcoming 2018-19 academic year.
The project will be focused on in vitro and in vivo characterization of nanoparticles for magnetic resonance imaging (MRI) in small animal mouse models as well as subsequent analysis of generated images. However, the student will have the option to work on other projects dealing with other imaging modalities and contrast agents depending on their interests.
Ideally, the student would be able to commit to working in the lab for a minimum of one year. Some Molecular Biology and MATLAB knowledge are highly preferred, but are not required.